RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Optimizing Treatment in Luminal Breast Cancer
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 15
SP 24
OP 26
DO 10.1177/155989771215017
UL http://mdc.sagepub.com/content/12/15/24.abstract
AB This article discussed the curability of luminal A and luminal B breast cancer subtypes, pharmacogenetics/pharmacogenomics to optimize endocrine therapy, new targeted agents in luminal breast cancer, as well as a review of whole genome sequencing for luminal-type breast cancer [Ellis MJ et al. Nature 2012].